angiotensin ii has been researched along with zoledronic acid in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, B; Chen, F; Han, J; Hu, SJ; Pan, YY; Yang, JX | 1 |
Chang, WC; Chen, JW; Huang, PH; Leu, HB; Lin, SJ; Peng, YJ; Tsai, HY; Tsai, SH | 1 |
2 other study(ies) available for angiotensin ii and zoledronic acid
Article | Year |
---|---|
Zoledronate attenuates angiogenic effects of angiotensin II-stimulated endothelial progenitor cells via RhoA and MAPK signaling.
Topics: Angiotensin II; Animals; Apoptosis; Base Sequence; Blotting, Western; Cells, Cultured; Diphosphonates; DNA Primers; Endothelium, Vascular; Flow Cytometry; Imidazoles; Male; MAP Kinase Signaling System; Neovascularization, Physiologic; Rats; Rats, Sprague-Dawley; rhoA GTP-Binding Protein; Signal Transduction; Stem Cells; Zoledronic Acid | 2012 |
Zoledronate attenuates angiotensin II-induced abdominal aortic aneurysm through inactivation of Rho/ROCK-dependent JNK and NF-κB pathway.
Topics: Angiotensin II; Animals; Anti-Inflammatory Agents; Aorta, Abdominal; Aortic Aneurysm, Abdominal; Cell Adhesion; Cell Line; Coculture Techniques; Dilatation, Pathologic; Diphosphonates; Disease Models, Animal; Dose-Response Relationship, Drug; Elastin; Endothelial Cells; Enzyme Activation; Humans; Imidazoles; JNK Mitogen-Activated Protein Kinases; Macrophages; Male; Matrix Metalloproteinase 2; Mice; Mice, Inbred C57BL; Mice, Knockout; Monocytes; NF-kappa B; Phosphorylation; Receptors, LDL; rho GTP-Binding Proteins; rho-Associated Kinases; rhoA GTP-Binding Protein; Signal Transduction; Vascular Cell Adhesion Molecule-1; Zoledronic Acid | 2013 |